Search NASA⌕ Search

SEARCH · Search NASA

Results for “interrupt”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 127 records · Page 7

Oridonin interrupts cellular bioenergetics to suppress glioma cell growth by down‐regulating PCK2

We aim to evaluate the tumor metabolic suppressive activity of Oridonin (extract of Rabdosia rubescens ) in glioma and elucidate its potential mechanism. Effects of Oridonin on U251/U87 cells were determined by CCK8, RTCA, colony formation, flow cytometry, wound healing, and Transwell assay. Xenograft tumor model to evaluate the effect of Oridonin on glioma cells in vivo. Cellular bioenergetics were measured by Seahorse. RNA‐seq was performed to screen potential biological pathways in Oridonin treated cells. Bioinformatics analysis of PCK2 in glioma was performed based on TCGA/CGGA. Endogenous PCK2 was knocked‐down by lentivirus packaged shRNA. We found Oridonin significantly inhibited cell growth in U251/U87 in vitro and in vivo. Both oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) were decreased in Oridonin‐treated U251/U87 cells. Oridonin treatment led to PCK2 down‐regulation. Additionally, PCK2 was up‐regulated in higher grade glioma and correlated with poor outcomes. Furthermore, PCK2 depletion significantly inhibited cell growth and decreased OCR/ECAR in U251/U87 which coincided with the effects of Oridonin. Therefore, we evaluated the potent anti‐tumor property of Oridonin in glioma. Importantly, we demonstrated that PCK2 might be a novel target of Oridonin on glioma by inducing energy crisis and increasing oxidative stress.

Lin, Jianhu↗

Stereotactic Radiosurgery: Treatment of Brain Metastasis Without Interruption of Systemic Therapy

Purpose: To evaluate the prevalence, outcomes, and toxicities of concurrent delivery of systemic therapy with stereotactic radiosurgery (SRS) for treatment of brain metastases. Methods and Materials: We conducted a retrospective review of 193 patients treated at our institution with SRS without prior whole-brain radiation therapy (WBRT) for brain metastases between 2009 and 2014. Outcome metrics included administration of concurrent systemic therapy, myelosuppression, neurotoxicity, and survival. Results: One hundred ninety-three patients with a median age of 61 years underwent a total of 291 SRS treatments. Thirty-seven percent of SRS treatments were delivered concurrently with systemic therapy, of which 46% were with conventional myelosuppressive chemotherapy, and 54% with targeted and immune therapy agents. Myelosuppression was minimal after treatment with both systemic therapy and SRS, with 14% grade 3-4 toxicity for lymphopenia and 4-9% for leukopenia, neutropenia, anemia, and thrombocytopenia. Neurotoxicity was also minimal after combined therapy, with no grade 4 and <5% grade 3 toxicity, 34% dexamethasone requirement, and 4% radiation necrosis, all similar to treatments with SRS alone. Median overall survival was similar after SRS alone (14.4 months) versus SRS with systemic therapy (12.9 months). In patients with a new diagnosis of primary cancer with brain metastasis, early treatment with concurrent systemic therapy and SRS correlated with improved survival versus SRS alone (41.6 vs 21.5 months, P<.05). Conclusions: Systemic therapy can be safely given concurrently with SRS for brain metastases: our results suggest minimal myelosuppression and neurotoxicity. Concurrent therapy is an attractive option for patients who have both intracranial and extracranial metastatic disease and may be particularly beneficial in patients with a new diagnosis of primary cancer with brain metastasis.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Deglaciation of the Greenland and Laurentide ice sheets interrupted by glacier advance during abrupt coolings

Understanding patterns of ice-sheet deglaciation is key for predicting the rate of future ice-sheet melt, yet the processes underlying deglaciation remain elusive. The early Holocene (11.7 ka to 8.2 ka; Greenlandian Stage) represents the most recent period when the Laurentide and Greenland ice sheets underwent large-scale recession. Moreover, this ice-sheet recession occurred under the backdrop of regional temperatures that were similar to or warmer than today, and comparable to those projected for the upcoming centuries. Reconstructing Laurentide and Greenland ice sheet behavior during the early Holocene, and elucidating the mechanisms dictating this behavior may serve as a partial analog for future Greenland ice-sheet change in a warming world. Here, we present 123 new 10 Be surface exposure ages from two sites on Baffin Island and southwestern Greenland that constrain the behavior of the Laurentide and Greenland ice sheets, and an independent alpine glacier during the early Holocene. On Baffin Island, we focus on a unique area where moraines deposited by the Laurentide Ice Sheet rest directly adjacent to moraines deposited by an independent alpine glacier. Sixty-one 10 Be ages reveal that advances and/or stillstands of the Laurentide Ice Sheet and an alpine glacier occurred in unison around 11.8 ka, 10.3 ka, and 9.2 ka. Sixty-two 10 Be ages from southwestern Greenland indicate that the Greenland Ice Sheet margin experienced re-advances or stillstands around 11.6 ka, 10.4 ka, 9.1 ka, 8.1 ka, and 7.3 ka. Our results reveal that ice sheets respond to climate perturbations on the same centennial timescale as small alpine glaciers. Further, we hypothesize that during the warming climate of the early Holocene, freshening of the North Atlantic Ocean induced by ice-sheet melt resulted in regional cooling and brief periods of ice-sheet stabilization superimposed on net glacier recession. These observations point to a negative feedback mechanism inherent to melting ice sheets in the Baffin Bay region that slows ice-sheet recession during intervals of otherwise rapid deglaciation.

58 GEOSCIENCES↗